ADAMIK, A. u. R. MISCHKE (1998):
Einfluss des Auswertungsverfahrens auf die Sensitivität der Resonanzthrombographie bei der Thrombozytopenie des Hundes.
Dtsch. Tierärztl. Wochenschr. 105, 405–407
AMMELOUNX, U. u. I. NOLTE (1987):
Untersuchung zur Wirksamkeit von Kortison bei gesunden Hunden mit physiologischer Thrombozytenzahl, aspirininduzierter Blutungsverlängerung und bei Hunden mit thrombozytopenischen Krankheitsbildern.
Berl. Münch. Tierärztl. Wschr. 100, 124–129
BALDUINI, C.L., G. BERTOLINO, P. NORIS u. G.C. PILETTA (1991):
Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders.
Am. J. Clin. Pathol. 95, 82–86
BARR, S.C., J.W. LUDDERS, A.L. LOONEY, R.D. GLEED u. H.N. ERB (1992):
Platelet aggregation in dogs after sedation with acepromazine and atropine and during subsequent general anesthesia and surgery.
Am. J. Vet. Res. 53, 2067–2070
BERGER, H. u. N- FREUDENBERG (1983):
Todesursachen bei Malignom-Patienten.
Med. Welt. 34, 112–118
BERTOLINO, G., P. NORIS u. C.L. BALDUINI (1991):
Qualitative and quantitative platelet defect with bleeding symptoms as presenting feature of non Hodgkin lymphomas.
Haematologica 76, 243–244
BELT, R.J., C. LEITE, C.D. HAAS u. L. STEPHENS (1978):
Incidence of hemorrhagic complications in patients with cancer.
J. Am. Med. Assoc. 239, 2571–2574
BORCHGREVINK, C.F. (1971):
Bleeding time techniques.
In: BANG, N.U., F.K. BELLER, E. DEUTSCH u. E.F. MAMMEN (Hrsg.):
Thrombosis and bleeding disorders.
Verlag Thieme, Stuttgart; Academic Press, New York, London, 56–78
BORN, G.V.R. (1962):
Aggregation of blood platelets by adenosin diphosphate and its reversal.
Nature 194, 927–929
BROOKS, M., u. J. CATALFAMO (1993):
Buccal mucosa bleeding time is prolonged in canine models of primary hemostatic disorders.
Thromb. Haemost. 70, 777–780
BRÜNING H., H.E. WANDER, J. BORGHART u. H. KÖSTRING (1983):
Beeinflussung der Hämostase durch Adriamycin.
In: H. KÖSTRING (Hrsg.):
Onkologie und Blutgerinnung.
Editions<Roche>, Basel, 149–161
CAIN, G.R., B.F. FELDMANN, T.G. KAWAKAMI u. N.C. JAIN (1986):
Patelet dysplasia associated with megakaryoplastic leukemia in a dog.
J. Am. Vet. Med. Assoc. 188, 529–530
CARCAO, M.D., J. DEAN, L. HE, A.M. STAIN, C.R. SPARLING, H. CHRISTENSEN, J.
FREEDMAN, V.S. BLANCHETTE u. M.L. RAND (1997):
Evaluation of platelet function in a pediatric setting using the platelet function analyzer (PFA-100).
Thromb. Haemost. 78 (Suppl.), PS–300
CARDINAL, D.C., u. R.J. FLOWER (1980):
The electronic aggregometer: a novel device for assessing platelet behaviour in blood.
J. Pharmacol. Meth. 3, 135–158
CATTANEO, M., A. LECCHI, B.AGATI, R. LOMBARDI u. M. L. ZIGHETTI (1999):
Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion.
Throm. Res. 96, 213–217
CHARBA, D., J.L.MOAKE, M.A. HARRIS u. J.P. HESTER (1993):
Abnormalities of von Willebrand factor multimers in drug-associated thrombotic microangiopathies.
Am. J. Hematol. 42, 268–277
CHOI, S. (1974):
Vincristine induced thrombocytosis.
In: BALDINI, M.G. u. S. EBBE (Hrsg.):
Platelets: Production, Function, Transfusion, and Storage.
Verlag Grune u. Stratton, New York, 57–71
CLEMMONS, R.M. u. K.M. MEYERS (1984):
Acquisition and aggregation of canine blood platelets: basic mechanisms of function and differences because of breed orgin.
Am. J. Vet. Res. 45, 137–144
COMP, P., E. LARKIN, R. GOSSELIN, C. GREENBERG, K. HOOTS, C. KESSLER, D. LILES, E. MAMMEN u. D. NUGENT (1997):
PFA-100 system: A new method for assessment of platelet dysfunction.
Thromb. Haemost. 78 (Suppl), PS–298
COUTO, C.G. (1985):
Clinicopatholologic aspects of acute leukemias in the dog.
J. Am. Vet. Med. Assoc. 186, 681–685
COWAN, D.H., R.C. GRAHAM u. D. BAUNACH (1975):
The platelet defect in leukemia.
J. Clin. Invest. 56, 188–200
DAVENPORT, D.J., E.B. BREITSCHWERDT und M.C. CARAKOSTAS (1982a):
Platelet disorders in the dog and cat . Part I. Physiologogy and pathogenesis.
Comp. Contin. Ed. Pract. Vet. 4, 762–772
DAVENPORT, D.J., E.B. BREITSCHWERDT und M.C. CARAKOSTAS (1982b):
Platelet disorders in the dog and cat . Part II. Physiologogy and pathogenesis.
Comp. Contin. Ed. Pract. Vet. 4, 788–792
DAVIS, R.B., A. THEOLOGIDES u. B.J. KENNEDY (1969) :
Comparative studies of blood coagulation and platelet aggregation in patients with cancer and nonmalignant diseases.
Ann. Int. Med 71, 67–80
DE GROOT, P. u. J.J. SIXMA (1990) : Platelet adhesion.
Br. J. Haematol. 75, 308–312
DE HAAN, J. u. H.-J. KOLDE (1996) :
Determination of the primary hemostasis potential of whole blood with PFA-100.
Ann. Hematol. 72 (Suppl I), A69
DIETRICH, G.V., V. KRETSCHMER, D. WEBER, W. HAUPT, B. LANGEN u. B. HUSS (1995):
Variables influencing the Thrombostat 4000. Recommended standardization.
Semin. Thromb. Hemost. 21, (Suppl.II), 11–19
DOMSCH, C., H. MÜLLER-BEIßENHITZ u. M. SPANNAGL (1999):
Einsatz des PFA 100 bei angeborenen und erworbenen hämorrhagischen Diathesen.
Hämostaseologie 19, 176–181
ELBERN, E. (1996):
Zu Veränderungen der Hämostase bei verschiedenen Tumorarten.
Aachen, Techn. Hochsch., Diss.
FABRIS, F., A. CASONATO u. M. DEL BEN GRAZIA (1986):
Abnormalities of von Willebrand factor in myeolproliferative disease: A relationship with bleeding diathesis.
Br. J. Haematol. 63, 75–83
FELLIN, F.M., C. BARSIGIAN, J. MARTINEZ u. W. BASE (1988):
Einfluß von Zytostatika auf das Gerinnungssystem.
Hämostaseologie 8, 18–26
FEINGOLD, H.M., L.E. PIVACEK, A.J. MELARAGNO u. C.R. VALERI (1986):
Coagulation assays and platelet aggregation patterns in human, baboon, and canine blood.
Am. J. Vet. Res. 10, 2197–2199
FINK, K. u. H. AL-MONDHIRY (1976):
Idiopathic thrombocytopenic purpura in lymphoma.
Cancer 37, 1999–2004
FORSYTHE, L.T., M.L. JACKSON u. S.M. MERIC (1989):
Whole blood platelet aggregation in uremic dogs.
Am. J. Vet. Res. 50, 1754–1757
FRENCH, A.J. u. J.S. LILLEYMAN (1979):
Bleeding tendency of T-cell lymphoblastic leukemia.
Lancet 2 (8140), 469–470
FRESSINAUD, E., A. VEYRADIER, M. TROSSAERT, F. TRUCHAUD, M. WOLF u. D. MEYER (1997) :
Screening and control of therapy of patients with von Willebrand disease using a new analyzer of platelet function under high shear stress.
Thromb. Haemost. 78 (Suppl), PS–2828
FRIMBERGER, A.E. (2000):
Anticancer drugs: new drugs or apllications for veterinary medicine.
In: KIRK, R.W. (Hrsg.):
Current veterinary therapy XIII. Small Animal Practice.
Verlag W.B. Saunders, Philadelphia, 474–478
GARRETT, L.D., D.H. THAMM, R. CHUN, R. DUDLEY u. D.M. VAIL (2002):
Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma.
J. Vet. Intern. Med. 16, 704–709
GAWAZ, M.P. (1999):
2. Thrombozyten und primäre Hämostase. 5. Funktionsdiagnostik.
In: GAWAZ, M. ( Hrsg.):
Das Blutplättchen
Verlag Thieme, Stuttgart, New York, 4–24, 42–53
GOLDEN, D.L. u. V.C. LAMGSTON (1988):
The use of vincristine and vinblastin in dogs and cats.
J. Am. Vet. Med. Assoc. 93, 1114–1117
GRALNICK, H.R., S. MARCHESI u. H. GIVELBER (1972):
Intravascular coagulation in acute leukemia: clinical and subclinical abnormalities.
Blood 40, 709–718
GRAU-BASSAS, E.R., G.J. KOCIBA u. C.G. COUTO (2000):
Vincristin impairs platelet aggregation in dogs with lymphoma.
J. Vet. Intern. Med. 14, 81–85
GRAUER, G.F., B.J. ROSE, L. TOOLAN, M.A. HULL THRALL u. S.P. COLGAN (1992):
Effects of low-dose aspirin and specific thromboxane synthetase inhibition on whole blood platelet aggregation and adenosine triphosphate secretion in healthy dogs.
Am. J. Vet. Res. 53, 1631–1635
GRINDEM, C.B., E.B. BREITSCHWERDT, W.T. CORBETT, H.E. JANS (1991):
Epidemiologic survey of thrombocytopenia in dogs: a report on 987 cases.
Vet. Clin. Pathol. 20, 38–43
GRINDEM, C.B., E.B. BREITSCHWERDT; W.T. CORBETT, R.L. PAGE u. H.E. JANS (1994):
Thrombocytopneia associated with neoplasia in dogs.
J. Vet. Int. Med. 8, 400–405
HANDAGAMA, P. u. B.F. FELDMAN (1988):
Thrombocytopenia and drugs.
Vet. Clin. North Am. Small Anim. Pract. 18, 51–65
HARTER, H. (1981):
Resonance-thrombographie, theoretical and practical elements.
Biorheology 18, 693–701
HEILMANN, E.J., S.K. KUNDU, R. SIO, C. GARCIA, R. GOMEZ u. D.J. CHRISTIE (1997):
Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA-100 system.
Thromb. Res. 87, 159–164
HEINMOLLER, E., R.J. WEINEL, H.H. HEIDTMANN (1996):
Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines.
J. Cancer Res. Clin. Oncol. 122, 735–744
HELFAND. S.C., C.G. COUTO u. B.R. MADWELL (1985):
Immune-mediated thrombocytopenia associated with solid tumors in dogs.
J. Am. Anim. Hosp. Assoc. 21, 787–794
HELFAND, S.C. (1988):
Platelets and neoplasia.
Vet. Clin. North Am. Small Anim. Pract. 18, 131–156
HENRY, C.J., A. LANEVSCHI, S.L. MARKS, J.C. BEYER, S.H. NITSCHELM u. S. BARNES (1996):
Acute lymphoblastic leukemia, hypercalcemia, and pseudohyperkalemia in a dog.
J. Am. Vet. Med. Assoc. 208, 237–239
HICSONMEZ, G. u. M. BUYUKPAMUKCU (1977):
Effect of cancer chemotherapy drugs on platelet aggregation in children.
Acta Haematol. 58, 312–317
HOAGLAND, H.C. (1984):
Hematologic complications of cancer chemotherapy.
In: PERRY, M.C. u. J.W. YARBRO (Hrsg.) Toxicity of chemotheraphy.
Verlag Grune und Stratton, Orlando, 443–448
HOELZER, D. u. N. GÖKBUGET (2003):
Akute lymphatische Leukämie.
In: SEEBER, S. u. J. SCHÜTTE (Hrsg.):
Therapiekonzepte Onkologie.
Verlag Springer, Berlin, 284–312
HONN, K.V., D.G. TANG u. Y.Q. CHEN (1992):
Platelets and cancer metastasis: more than an epiphenomenon.
Semin. Thromb. Hemost 18, 392–415
JACKSON, C.W. u. C.C. EDWARDS (1977):
Evidence that stimulation of megakaryocytopoiesis low dose vincristine results from effect an platelets.
Br. J. Haematol. 101, 41–44
JAIN, N.C. (1989):
Cytochemistry of canine and feline leukocytes and leukemias.
In: KIRK, R.W. (Hrsg.):
Current veterinary therapy X. Small Animal Practice.
Verlag W.B. Saunders, Philadelphia, 465–468
JAIN, N.V. and J.W. SWITZER (1981):
Autoimmune thrombocytopenia in dogs and cats.
Vet. Clin. North Am. Small Anim. Pract. 11, 421–434
JERGENS, A.E., M.A. TURRENTINE, K.H. KRAUS u. G.S. JOHNSON (1987):
Buccal mucosa bleeding times of healthy dogs and dogs in various pathologic states, including thrombocytopenia, uremia, and von Willebrand´s disease.
Am. J. Vet. Res. 48, 1337–1342
JUTTNER, C., M. RODRIGUEZ u. C. FRAGIO (2000):
Optimal conditions for simultaneous measurement of platelet aggregation and ATP secretion in canine whole blood.
Res. Vet. Sci. 68, 27–32
KAPTAN, K, C. BEYAN, B. OZTURK, T. CETIN, A. U. URAL, F. AVCU, C. USTUN u. A.
YALCIN (2002):
Lack of platelet aggregation abnormality in Hodgkin´s disease.
Haematologia (Budapest) 31, 357–363
KARGER, R., K. GUTENSOHN, M. BÖCK, K.-H. BECK, K.-H. HERTFELDER u. V.
KRETSCHMER (1997):
PFA-100 closure time. Reference range for blood in 3,2% buffered citrat.
Infusionsther. Transfusionsmed. 24, (Suppl.II), 11–19
KARNOFSKY, D.A. (1969):
Cancer chemotherapeutic agents.
Cancer 18, 80
(zitiert nach HANDAGAMA 1988)
KARPATKIN, S. (1980):
Autoimmune thrombocytopenic purpura.
Blood 56, 329–343
KEIDEL, A.H. (2001):
Methodische und klinische Untersuchung mit dem Plättchenfunktionsanalysengerät PFA-100 beim Hund.
Hannover, Tierärztl. Hochsch., Diss.
KEIDEL, A. u. R. MISCHKE (1998):
Untersuchung zur klinischen Anwendung des Plättchenfunktionsanalysengerätes PFA-100 beim Hund.
Berl. Münch. Tierärztl. Wschr. 111, 452–456
KISSBERTH, W.C. u. E.G. MACEWEN (2001).
Complications of cancer and ist treatment.
In: WITHROW, S.J. u. E.G. MACEWEN (Hrsg.):
Small Animal Clinical Oncology. Third Edition Verlag W.B. Saunders, Philadelphia 203–219
KLEIN, A., A. ADAMIK u. R. MISCHKE (1999):
Lagerungsbedingte Veränderung im Thrombozytenkonzentrat des Hundes.
Teil I: Zahl und In-vitro-Funktionsfähigkeit der Thrombozyten.
Berl. Münch.Tierärztl. Wochenschr. 112, 243–253
KLENER, P., L. DONNER und J. HOUSKOVA(1972):
Thrombocytosis in rats induced by vinblastin.
Haemostasis 1, 73–78
KLENER, P., P. KUBISZ u. J. SURANOVA (1977):
Influence of cytotoxic drugs on platelet functions and coagulation in vitro. IV. Melphalan.
Thromb. Haemost. 37, 53–61
KOCIBA, G. J. (1976):
The diagnosis of hemostatic disorders.
Vet. Clin. North. Am. Small Anim. Pract. 6, 609–623
KRETSCHMER, V., D. WEBER, u. G. DIETRICH (1990):
Methodical evaluation of the in vitro bleeding test.
Blut 60, 132
KRETSCHMER, V, u. M. WEIPPERT-KRETSCHMER (1999):
Determination and treatment of disorders of primary haemostasis.
Hämostaseologie 19, 168–175
KUNDU, S., R. SIO, A.MITU u. R. OSTERGAARD (1994) : Evaluation of platelet function by PFA-100.
Clin. Chem. 40, 1827–1828
KUNDU, S.K., E.J. HEILMANN, R. SIO, C. GARCIA, R.M. DAVIDSON u. R.S. OSTGAARD (1995):
Description of an in vitro platelet function analyzer-PFA-100.
Semin. Thromb. Hemost. 21, (Suppl. II), 106–112
KUNDU, S.K., E.J. HEILMANN, R. SIO, C. GARCIA u. R.A. OSTERGAARD (1996):
Characterization of an in vitro platelet function analyzer, PFA-100.
Clin. Appl. Thromb. Hemost. 2, 241–249
LEIFER, C.E., u. R.E. MATUS (1986):
Chronic lymphocytic leukaemia in the dog: 22 cases (1974-1984).
J. Am. Vet. Med. Assoc. 189, 214–217
LEINOE, E.B., M.H. HOFFMANN, E. KJAERSGAARD u. H.E. JOHNSEN (2004):
Multiple platelet defects identified by flow cytometry at diagnosis in acute myeloid leukaemia.
Br. J. Haematol. 127, 76–84
LEMANCZYK S., B. PODOLSAK u. W. BOHNDORF (1976):
Veränderung der Thrombozytenadhäsion, -aggregation und -ausbreitung durch Zytostatika und Hartstrahlenbehandlung.
In: GASTPAR, H. (Hrsg.):
Onkohämostaseologie.
Verlag Schattauer, Stuttgart, New York, 51–56
LEVIN J. (1978):
Chemotherapy and thrombopoiesis.
In: Brodsky I.(Hrsg.):
Cancer Chemotherapy III: Forty-Sixth Hahnemann symposium.
Verlag Grune & Stratton, New York, 313–325
LICHTENFELD, K.M. u. C.A. SCHIFFER (1979):
The effect of dexamathason on platelet function.
Transfusion 19, 169–172
LICHTMANN, M.A. u. J.K. BRENNAN (1987):
Platelet production and destruction.
In: Hemostatsis and Thrombosis.
COLMAN, R.W., J. HIRSCH, V.J. MARDER u. E.W.SALZMAN (Hrsg.) Lippincott, Philafelphia, 395–417
LINK, M. u. J. HIRSCHBERGER (1999):
Maligne Lymphome und lymphatische Leukämien. Eine Literaturübersicht.
Tierärztl. Prax. 27, 29–38
MACKIN, A.J., D.G. ALLEN u. I.B. JOHNSTONE (1995):
Effects of vincristine and prednisone on platelet numbers and function in clinically normal dogs.
Am. J. Vet. Res. 56, 100–108
MADEWELL, B.R. (1986):
Hematological and bone marrow cytological abnormalities in 75 dogs with malignant lymphomas.
J. Am. Anim. Hosp. Assoc. 22, 235–240
MADEWELL, B.R., B.F. FELDMANN u. S.O`NEILL (1980):
Coagulation abnormalities in dogs with neoplastic disease.
Thromb. Haemost. 44, 35–38
MAEDA, H., K. OZAKI, S. HONAGA u. I. NARAMA (1993):
Hodgkin´s like lymphoma in a dog.
Zentralbl. Veterinarmed. A. 40, 200–204
MALIK, U., J.P. DUTCHER u. U.L. OLEKSOWICZ (1998):
Acquired Glanzmann´s thrombozytopenia associated with Hodgkin´s lymphoma.
Cancer 82, 1764–1768
MAMMEN, E. R.S. ALSHAMEERI u. P.C. COMP (1995):
Preliminary data from a field trial of the PFA-100 system.
Semin. Thromb. Hemost. 21, (Suppl. II), 107–113
MATERA, C., C. FALZARANO, C. VACCA, M. FALCIANI u. F. ROSSI (1994):
Effects of some antineoplastic drugs (vincristine, doxorubicin and epirubicin) on human platelet aggregation.
J. Med. 25, 2–16
MATUS, R.E., C.E. LEIFER u. E.G. MACEWEN (1983):
Acute lymphblastic leukemia in the dog: a review of 30 cases.
J. Am. Vet. Med. Assoc. 183, 859–862
MATZDORFF, A.C., G. KUHNEL, B. KEMKES-MATTHES u. H. PRALLE (1998):
Quantitative assessment of platelets, platelet micropaticles, and platelet aggregates with flow cytometry.
J. Lab. Clin. Med. 131, 507–517
MCNIEL, E.A., G.K.OGILVIE, M.J. FETTMAN u. M.D. SALMAN (1997):
Platelet hyperfunction in dogs with malignancies.
J. Vet. Intern. Med. 11, 178–182
MIELKE, C.H., M.M. KANESHIRO, I.A. MAHER, J.M. WEINER u. S.I. RAPAPORT (1969):
The standardized normal Ivy bleeding time and ist prolongation by aspirin.
Blood 34, 204–215
MISCHKE, R., u. K. NIMMERFALL (2000):
Wirkung einer einmaligen hohen subkutanen Dosis unfraktionierten Heparins auf die Thrombozytenfunktion beim Hund.
Berl. Münch. Tierärztl. Wochenschr. 113, 60–64
MISCHKE, R. u. A. KEIDEL (2002):
Präklinische Untersuchung zur Anwendung des Plättchenfunktionsanalysegerätes PFA-100 mit der Kollagen/ADP-Messzelle beim Hund.
Dtsch. tierärztl. Wschr. 109, 235–238
MISCHKE, R. u. A. KEIDEL (2003):
Influence of platelet count, acetylsalicylic acid, von Willebrand´s disease,
coagulopathies and hematocrit on results obtaining using a platelet analyser in dogs.
Vet. J. 165, 43–52
MISCHKE, R. u. U. SCHULZE (2004):
Studies on platelet aggregation using the Born method in normal and uraemic dogs.
Vet. J. 168, 270–275
MISCHKE, R., M. FREUND, T. LEINEMANN-FINK, B. EISENBERGER, J. CASPER u. I.
NOLTE (1998):
Veränderung der Hämostase bei Hunden mit akuter Lymphoblastenleukämie.
Berl. Münch. Tierärztl. Wochenschr. 105, 53–59
MOHRI, H. (1986):
Acquired von Wilebrand disease and storage pool disease in chronic myelocytic leukemia.
Am. J. Hematol. 22, 391–401
MOORE, G.E., E.A. MAHAFFEY u. M. HOENIG (1992):
Hematologic and serum biochemical effects of long-term administration of anti-inflammatory doses of prednisone in dogs.
Am. J. Vet. Res. 53, 1033–1037
MOORE, A.S. u. B.E. KITCHELL (2003):
New chemotherapy agents in veterinary medicine.
Vet. Clin. North Am. Small Anim. Pract. 33, 629–649
MORITZ, A., B.K. WALCHECK u. D.J. WEISS (2003):
Flow cytometric detection of activated platelets in the dog.
Vet. Clin. Pathol. 32, 6–12
MORRISON-COLLISTER, K.E., K.M. RASSNICK, N.C. NORTHRUP, O. KRISTAL, J.D.
CHRETIN, L.E. WILIAMS, S.M. COTTER u. A.S. MOORE (2003):
A combination chemotherapy protocol with MOPP and CCNU consolidation (Tufts VELCAP-SC) for the treatment of canine lymphoma.
Vet. Comp. Oncol.1, 180–190
MÜLLER-BERGHAUS (1997):
Hämostatische Funktion der Endothelzelle.
Hämostaseologie 17, 78–85
MÜLLER, M., K. BECKER-HAGENDORF, D. WESTRUP, E. SEIFRIED u. C.M.
KIRCHMAIER (1997):
PFA-100 system: A sensitive screening test for platelet-related hemostasis defects.
Ann. Hematol. 74 (Suppl. II), A78
NAGY, I. u. H. LOSONCZY (1987):
Haemostatic alterations in lymphomas and tumors.
Acta. Med. Hung. 44, 71–82
NARESH, K.N., P. SIVASANKARAN u. A.J. VELIATH (1992):
Platelet function in chronic leukemias.
Indian J. Cancer 92, 49–55
NARESH, K.N., P. SIVASANKARAN u. A.J. VELIATH (1993):
Platelet function in acute leukemias.
J. Assoc. Physicians India 41, 377–378
NOLTE, I. u. R. MISCHKE (1995):
Investigation of platelet aggregation and platelet counts from stored canine whole blood.
Res. Vet. Sci. 58, 190–192
NOLTE, I., R. MISCHKE, U. AMMELOUNX, C. NIEMAND u. P.M. HEYDE (1994):
Diagnostische und therapeutische Aspekte thrombozytenabhängiger Hämostasestörung beim Hund.
Kleintierpraxis 39, 709–726
NOLTE, I., C. NIEMANN, S. K. BOWRY, F. FAILING u. G. MÜLLER-BERGHAUS (1997):
A method for measuring capillary bleeding time in nonanaesthetized dogs and their prolongation by acetylsalicyclic acid.
J. Vet. Med. A 44, 625–628
O`DONNELL, M.R., S.J. SLICHTER u. P.L. WEIDEN(1981):
Platelet and fibrinogen kinetics in canine tumors.
Cancer Res. 41, 1379–1383
OGSTON, D. u. A.A. DAWSON (1969):
Thrombocytosis following thrombocytopenia in man.
Postgrad. Med. J. 45, 754–756
PACKHAM, M.A., N.L. BRYANT, M.A. GUCCIONE, R.L. KINLOUGH-RATHBONE u. J.F.
MUSTARD (1989):
Effect of the concentration of Ca2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents.
Thromb. Hemostatis. 62, 968–976
PATSCHKE, H. u. A. RUF (1998):
Thrombozyten-Funktionstests.
In: L. THOMAS (Hrsg.):
Labor und Diagnose. 5. Auflage
TH-Books-Verlag, Frankfurt/Main, 610–612
PETURSSON, S.R.u P.A. CHERVNICK (1982):
Megakaryocytopoiesis and granulopoiesis following cyclophosphamide.
J. Clin. Lab. Invest. 100, 682–694
PRIEST, J.R. u. N.K.C. RAMSEY (1982):
A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia.
J. Pediatr. 100, 984–989
PUI, C-H., D.L. WILLIAMS, V. SCARBOROUGH, C.W. JACKSON, R. PRICE u. S. MURPHY (1982):
Acute megakaryoplastic leukemia associated with intrinsic platelet dysfunction and constitutional ring 21 chromosone in a young boy.
Br. J. Haematol. 50, 191–200
PUI, C.H., C.W. JACKSON, C. CHESNEY, S.A. LYLES, W.P. BOWMAN, M.
ABROMOWITCH u. J.V. SIMONE (1983):
Sequential changes in platelet function and coagulation in leukemic children treated with L-asparaginase, prednisone, and vincristine.
J. Clin. Oncol. 1, 380–386
PUI, C.H., C.M. CHESNEY, J. WEED u. C.W. JACKSON (1985):
Altered von Willebrand factor molecule in children with thrombosis following asparaginase-prednisone-vincristine therapy for leukemia.
J. Clin. Oncol. 3, 1266–1276
PUI, C.H., C.W. JACKSON, C.M. CHESNEY u. C.F. ABILDGAARD (1987):
Involvement of von Willenrand factor in thrombosis following asparaginase-prednisone-vincristine therapy for leukaemia.
Am. J. Hematol. 25, 291–298
RAMOS, O.F., E.C. MORON u. R. DE CASTRO ARENAS (1981) : Platelet function abnormalities in acute leukaemia.
Haemotologia (Budapapest) 14, 383–391
RATZAN, R.J., S. ZUCKER u. L.R. WEINTRAUB (1972):
The mechanism responsible for vincristine-induced thrombocythemia.
Blood 40, 965
RINDER, M.R., R.E. RICHARD u. H.M. RINDER (1997):
Acquired von Willebrand´s disease: a concise review.
Am. J. Hematol. 54, 139–145
ROBERTSON, J.H. , E.H. CROZIER u. B.E. WOODEND(1970):
The effect of vincristine on the platelet count in rats.
Br. J. Haematol. 19, 331–337
ROBERTSON, J.H., E-H- CROZIER u. B.E. WOODEND(1972):
Vincristin-induced thrombocytosis studied with 75Se selenomethionin.
Acta Haematol. 74, 356–360
ROGERS, K.S. (1992):
Coagulation disorders associated with neoplasia in the dog.
Vet. Med. Small Animal Clin. 12, 55–61
ROGERS, K.S., C.L. BARTON, P.A. BENSON u. R.A. GREEN (1992):
Effects of single-dose L-asparaginase on coagulation values in healthy dogs and dogs with lymphoma.
Am. J. Vet. Res. 53, 580–584
ROSENFELD, S.J. u. H.R. GRALNICK (1997):
Adhesive interactions in hemostasis.
Acta Haematol. 97, 118–125
ROSENTHAL, M.C., J. NIEMITZ u. N. WISCH (1963):
Hemorrhage and thromboses associated with neoplastic disorders.
J. Chron. Dis. 16, 667–675
ROZANSKI, E.A., M.B. CALLAN, D. HUGHES, N. SANDERS u. U. GIGER (2002):
Comparison of platelet count recovery with use of vincristine and prednisone or prednisone alone for treatment for severe immune-mediated thrombocytopenia in dogs.
J. Am. Vet. Med. Assoc. 4, 477–481
RUGGERI, Z.M. (1994):
New insights into the mechanisms of platelet adhesion and aggregation.
Semin. Hematol. 31, 229–239
SANIABADI, A.R., G.D. LOWE, J.C. BARBENEL u. C.D. FORBES (1984):
A comparison of spontaneous platelet aggregation in whole blood with platelet rich plasma:
additional evidence for thr role of ADP.
Thromb. Haemost. 51, 115–118
SARRIS, A., L. CORTES, H. KANTARJIN, S. PIERCE, T. SMITH, M. KEATING, C. KOLLER, S. KORNBLAU, S.O´BRIEN u. M. ANDREEFF (1996):
Disseminated intravascular coagulation in adult acute lymphoblastic leukaemia: frequent complications with fibrinogen levels less than 100 mg/dl.
Leuk. Lymphoma 21, 85–92
SCHAFER, A.I. (1984):
Bleeding and thrombosis in the myeloproliferative disorders.
Blood 64, 1–12
SCHALM, O.W., N.C. JAIN u. E.J. CARROLL (1975):
The blood platelets.
In: O.W. SCHALM, N. JAIN u. E.J. Carroll (Hrsg.):
Veterinary Hematology. 3.Aufl.
Verlag Lea & Febiger, Philadelphia, 336–355
SCHARF, R.E. (1996):
Molecular basis and clinical aspects of hereditary megakaryocyte and platelet membrane glycoprotein disorders.
Hämostaseologie 16, 114–138
SCHARF, R.E. (1997):
I. Normales hämatopoetisches System. 6. Thrombozytäres System.
In: OSTENDORF, P.C. u. S. SEEBER (Hrsg.):
Hämatologie, Onkologie.
Verlag Urban & Schwarzenberg, München, 49–64
SCHERMERHORN, T., S.C. BARR, D.A. STOFFREGEN, Y. KOREN-ROTH u. H.N. ERB (1994):
Whole-blood platelet aggreagation, buccal mucosa bleeding time, and serum cephalithin concentration in dogs receiving a presurgical antibiotic protocol.
Am. J. Vet. Res. 55, 1602–1607
SCHRÖR, K. (1991):
Plättchenfunktionshemmer – neue pharmakologische Ansätze.
Hämostaseologie 11, 66–75
SCHULZE, U. (1998):
Untersuchung zur Thrombozytenaggregation beim Hund.
Hannover, Tierärztl. Hochsch., Diss.
SCHWARZ, H.P., P.L. TURECER, L. PICHLER, A. MITTERER, W. MUNDT, F. DORNER, J.
ROUSSI u. L. DROUET (1997):
Recombinant von Willebrand factor.
Thromb. Haemost. 78, 571–576
SEARCY G.P. (1980):
Bone marrow failure in the dog and cat.
In: KIRK, R.W. (Hrsg.):
Current Vetereinary Therapy VII. Small Animal Practice.
Verlag W.B. Saunders Co. Philadelphia, 413–416
SHAPIRO, R.S., J.M. GERRARD, N.K. RAMSAY, M.E. NESBIT, P.F. COCCIA, S.F.
STODDARD, E.F. PLOW, J.G. WHITE u. W. KRIVIT (1980):
Selective deficiency in collagen-induced platelet aggregation during L-asparaginase therapy.
Am. J. Pediatr. Hematol. Oncol. 2, 207–212
SLICHTER, S.J. u. L.A. HARKER (1974):
Hemostasis in malignancy.
Ann. NY Acad. Sci. 230, 252–261 (Abstract)
SOLOVIEV, M.V., Y. OKAZAKI u. H. HARASAKI (1999):
Whole blood platelet aggregation in humans and animals: a comparative study.
J. Surg. Res. 82, 180–187
SPEISER, W., I. PABINGER-FASCHING, P.A. KYRLE, S. KAPIOTIS, A. KOTTAS-HELDENBERG, P. BETTELHEIM u. K. LECHNER (1990):
Hemostatic and fibrinolytic parameters in patients with acute myeloid leukemia: Activation of blood coagualtion, fibrinolysis and unspecific proteolysis.
Blut 61, 298–302
STEINHERZ, P.G., D.R. MILLER, M.W. HILGARTNER u. E.A.SCHMALZER (1976):
Platelet dysfunction in vincristin treated patients.
Br. J. Haematol. 32, 439–450
STEPANIAN, A. u. C. BIRON-ANDREANI (2001):
Primary hemostasis exploration.
Ann. Biol Clin (Paris) 6, 725–735
STOCKHAM, S.L., K.S. KEETON u. B. SZLADOVITS (2003):
Clinical assessment of leukocytosis: distinguishing leukocyctoses caused by inflammatory, glucocorticoid, physiologic, and leukemic disorders or conditions.
Vet. Clin. North Am. Small Anim. Pract. 33, 1335–1357
SUN, N.C.J., W .M. MCAFEE, G.J. HUM u. J.M. WEINER (1979) :
Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I.
Coagulation studies.
Am. J. Clin. Pathol. 71, 10–16
SUTOR, A.H., J. WULFF, J. RITTER, J. POLLMANN u. G. SCHELLONG (1984):
Hemostasis and fibrinolysis in acute lymphoblastic leukemia (ALL) in childhood – analysis of life-threatening bleeding.
Klin. Padiatr. 196, 166–173
TAKANO, S. (1981):
Difference in effects of vinblastine and vincristine on the dog platelet aggregation.
Tohoku. J. Exp. Med. 135, 79–85 (Abstract)
TALLMANN, M.S., D. HAKIMIAN, H.C. KWAAN u. F.R. RICKLES (1993):
New insights into the pathogenesis of coagulation dysfunction in acute promyelotic leukemia.
Leuk. Lymphoma 11, 27–36
TESKE, E. (1994):
Canine malignant lymphoma: a review and comparison with human non- Hodgkin´s lymphoma.
Vet Quart 16, 209–219
THOMAS, J.S. u. K.S. ROGERS (1999):
Platelet aggregation and adenosine trisphosphate secretion in dogs with untreated multicentric lymphoma.
J. Vet. Intern. Med 13, 319–322
THRALL, M.A. (1981):
Lymphoproliferative disorders: Lymphocytic leukemia and plasma cell myeloma.
Vet. Clin. North Am. Small Anim. Pract. 11, 321–347
UESUGI, Y., I. FUSE, K. TOBA, T. KOIKE u. A. SHIBATA (1997):
Aquired immune thrombocytopenia caused by IgG antiglycoprotein Ib antibody in a patient with Hodgkin´s disease.
Acta Haematol. 98, 217–220
VAIL, D.M., E.G. MACEWEN u. K.M. YOUNG (2001):
Canine lymphoma and lymphoid leukemias.
In: WITHROW, S.J. u. E.G. MACEWEN (Hrsg.):
Small Animal Clinical Oncology. Dritte Auflage.
Verlag W.B. Saunders, Philadelphia, 558–590
VAN DER WEYDEN, M.B., R.L. CLANCY, M.A: HOWARD u. B.G. FIRKIN (1972):
Qualitative platelet defects with reduced life-span in acute leukaemia.
Australien and new Zealand Journal of Medicine 2, 339–345
VERICEL, E., M. CROSET, P. SEDIVY, P. COURPRON, M. DECHAVANNE u. M. LAGARDE (1988):
Platelets and aging. I—Aggregation, arachidonate metabolism and antioxidant status.
Thromb. Res. 49, 331–342
VERNAU, W. u. P.F. MOORE (1999):
An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction.
Vet. Immunol. Immunpathol. 69, 145–164
WHITE, J.G. (1969):
Effects of colchicines and vinca alkaloids on human platelets. III. Influence on primary internal concentration and secondary aggregation.
Am. J. Pathol. 54, 467–478
WHITE, J.G. (1996):
Morphological and functional aspects of cellular hemostatic mechanisms.
Hämostaseologie 16, 78–87
WHITECAR, J.P.Jr., G.P. BODEY, J.E. HARRIS u. E.J. FREIREICH (1970):
L-asparaginase.
N. Engl. J. Med. 13, 732–734
WILLIAMS, C.E., M.B.P. ENTWISTLE u. P.E. SHORT (1985):
Platelet function tests: a critical review of methods.
Med. Lab. Sci. 42, 262–274
WILMER, M., R. SIO, H.-J. KOLDE u. J. DE HAAN (1997):
Characterization of preanalytical and technical variables when using the PFA-100 test system.
Ann. Hematol. 74, (Suppl II), A117 (Abstr.)
WOODCOCK, B.E., P.C. COOPER, P.R. BROWN, C. PICKERING, D.A. WINFIELD u.
F.E.PRESTON (1984):
The platelet defect in acute myeloid leukemia.
J. Clin. Pathol. 37, 1339–1342
WORKMAN, H.C. u. W. VERNAU (2003):
Chronic lymphocytic leukaemia in dogs and cats: the veterinary perspective.
Vet. Clin. North Am. Small Anim. Pract. 33, 1379–1399
WUILLEMIN, W.A., K.M. GASSER, S.S. ZEERLEDER u. B. LAMMLE (2002):
Evaluation of a platelet function analyzer (PFA-100) in patients with a bleeding tendency.
Swiss. Med. Wkly. 132, 443–448
WUILLEMIN, W.A. u. M. HEIZMANN (2003):
Interpretation of screening tests of hemostasis.
Schweiz. Rundsch. Med. Prax. 92, 57–64
YAHARA, Y., S. OKAWA u. Y. ONOZAWA (1983) :
Activation of platelets in cancer, especially with reference to genesis of disseminated intravascular coagulation.
Thromb. Res. 29, 27–35
ZURBORN, K.H., H. DUSCHA, J. GRAM u. H.D. BRUHN (1990):
Investigation of coagulation system and fibrinolysis in patients with disseminated adenocarcinomas and Non-Hodgkin´s lymphoma.
Oncology 47, 376–380
ZUBORN, K.H. u. H.D. BRUHN (1990):
Paraneoplastische Hämostasestörungen.
Internist (Berlin) 31, 526–531